Combining new drug with chemotherapy extends survival of platinum-resistant ovarian cancer patients in clinical trial
Platinum-based chemotherapy is a standard treatment for ovarian cancer, but its effectiveness can be limited in some cases. In some patients, the disease returns or progresses within six months of the last platinum dose, ...









